acarix Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 02 May 2023 Idag inleds nyttjandeperioden för Acarix teckningsoptioner av serie 2022:U Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission... Continue reading
acarix Annual, English, IR, Listing Regulation, News, Regulatory, Report November 18, 2024 20 Apr 2023 Acarix AB’s Annual Report 2022 Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces that the Annual Report for 2022 is available as a pdf on... Continue reading
acarix Annual, IR, Listing Regulation, News, Regulatory, Report, Swedish November 18, 2024 20 Apr 2023 Acarix AB’s Årsredovisning 2022 Acarix, ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att årsredovisning för 2022 finns tillgä... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory November 18, 2024 11 Apr 2023 Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on T... Continue reading
acarix Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish November 18, 2024 11 Apr 2023 Kallelse till årsstämma i Acarix AB Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till årsstämma torsdagen den 11 maj 2023 kl... Continue reading
acarix Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares November 18, 2024 04 Apr 2023 Acarix carries out a directed share issue amounting to approximately SEK 9.5 million THIS PRESS RELEASE IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, ... Continue reading
acarix Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish November 18, 2024 04 Apr 2023 Acarix genomför en riktad nyemission om cirka 9,5 MSEK DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELL... Continue reading
acarix Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory November 18, 2024 21 Feb 2023 Acarix receives breakthrough order from US Veterans Health Administration Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today the first order from the US Veterans Health Administrati... Continue reading
acarix Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 21 Feb 2023 Acarix erhåller genombrottsorder från US Veterans Health Administration Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, bekräftar idag att bolaget erhållit den första order... Continue reading
acarix Interim, IR, Listing Regulation, News, Regulatory, Report, Swedish, Yearend November 18, 2024 16 Feb 2023 Acarix AB (publ) publicerar Bokslutskommuniké 2022 Strategiskt skifte till fullt kommersiellt fokus på USA-marknaden nu på platsNär vi summerar 2022 blir det tydligt att... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend November 18, 2024 16 Feb 2023 Acarix AB (publ) publishes Year-End Report 2022 Strategic shift towards full commercial focus on the US market now in placeAs we sum up 2022, it becomes clear that Acarix has in a sho... Continue reading
acarix Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares November 18, 2024 23 Jan 2023 Acarix announces last day of trading with BTU and first day of trading in warrants THIS ANNOUNCEMENT IS NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, C... Continue reading